Global Enteral Stenting Procedures Market - 2022-2029

Global Enteral Stenting Procedures Market - 2022-2029

Market Overview

Enteral Stenting Procedure Market size was valued at US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 5.2% during the forecast period (2022-2029).Enteral stenting is a nonsurgical outpatient procedure that is employed to eliminate an obstruction caused by a cancerous tumor within the digestive tract, including the upper gastrointestinal (GI) tract (esophagus, stomach, and upper part of the small intestine or duodenum) and lower GI tract (colon and rectum).

Market Dynamics

The growing number of cancer cases across the globe, rapidly changing living conditions, and increasing demand for minimally invasive treatment methods are some of the main reasons for the market’s growth.

The high prevalence of gastric cancer is driving the global market growth.

The rising cases of gastric cancer are driving the global market growth. For instance, statistics from the GLOBOCAN database indicate that over 1.1 million people were diagnosed with gastric cancer globally in 2020, with around 770,000 subsequent deaths; concerning these rates, it is estimated that there will be 1.8 million cases and 1.3 million deaths by 2040. Furthermore, as per the World Cancer Research Fund International, in 2020, over 1.9 million new cases of colorectal cancer were diagnosed. Moreover, according to the Global Cancer Observatory, in 2020, around 935,173 people died of colorectal cancer, accounting for 515,637 males and 419 536 females. Also, with the increasing age, the chances of getting colorectal cancer increase; therefore, the growing geriatric population is fueling the global market growth. According to the WHO, the share of the population aged 60 was 1 billion in 2020 and is estimated to be 2.1 billion by 2050. For every 5-year increase in the adult age group, the incidence rate doubles until age 50.

The safety concerns with the procedure are expected to hinder global enteral stenting procedures market growth.

However, the safety concerns regarding the use of stents and the risks involved will slow down the growth of the global enteral stenting procedure market during the forecast period.

COVID-19 Impact Analysis

During the pandemic, different restriction policies were employed, which restricted transportation and socializing, causing disruption in the supply and demand chain and leading to the un-meeting of the market demand. Furthermore, with the socializing restriction, the diagnosis was not possible as regular health check-ups were difficult to perform, leaving a majority of gastric and colonic cancer cases undetected, negatively impacting the global enteral stenting procedures market.

Segment Analysis

Self-expanding metal stents are assumed to command the enteral stenting procedures market throughout the forecast period (2022-2029).

The benefits offered by the self-expanding metal stents, such as those placed within a malignant stricture, exert a greater radial force against the tumor, allowing the lumen to open once again, improving the patient’s quality of life. They are composed of various materials: stainless steel, elgiloy (Cobalt-Chromium-Nickel-Molybdenum alloy) and nitinol (nickel and titanium alloy) and come in various sizes and lattice widths. Furthermore, these stents can come covered with a coating over the mesh or uncovered; the covered stents prevent tumor ingrowth while uncovered stents enmesh with the GI wall and are less likely to be displaced. Since each manufacturer’s stent design and delivery system is different and with attention to the fluoroscopic image, some stents can be recaptured/repositioned if 50% or less of the stent has been deployed, such advancements in the SEMS are ensuring their dominance over the global market during the forecast period (2022-2029).

Geographical Analysis

The Asia Pacific region dominates the global enteral stenting procedures market.

The Asia Pacific is predicted to have a large share of the global market during the forecast period (2022-2029), owing to the rising incidences of the stomach and colorectal cancer in this region. For instance, according to Global Cancer Observatory WHO, in 2020, there were around 656349 new cases with 435211 deaths of stomach cancer and 757849 new cases and 368072 deaths of colorectal cancer; in South-Eastern Asia, there were 39763 new cases and 32814 deaths occurred of stomach cancer with 106995 new cases and 57064 deaths of colorectal cancer; in South-Central Asia, there were around 102676 new cases with 89595 deaths of stomach cancer. Also, 102987 new cases with 59206 deaths of colorectal cancer, and Western Asia observed 21156 new cases with 17586 deaths with gastric cancer along with 41569 new cases and 22107 deaths of colorectal cancer; making the Asia Pacific region with the highest stomach cancer and colorectal cancer prevalence, ensuring the dominance of Asia Pacific over the global market.

Competitive Landscape

Some key players dominate the enteral stenting procedures market, which include Cook Group Inc, Boston Scientific Corp, Merit Medical Systems Inc, Micro-Tech Nanjing Co Ltd, Olympus Corporation, Taewoong Medical Co Ltd, M.I.Tech Co., Ltd., ACE Medical Devices Pvt. Ltd., Allium Ltd., ENDOCOR GmbH & CO. KG and Others. These key players adopt market strategies like product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the growth of the enteral stenting procedures market globally. For instance, in May 28, 2021, Olympus Corporation acquired Medi-Tate, an Israeli medical device company. Also, in May 02, 2022, Cook Medical’s Winston-Salem manufacturing facility secured ISO 14001 certification.

Boston Scientific Corporation

Overview:

Boston Scientific was founded in 1979 and is headquartered in Marlborough, Massachusetts, U.S. Boston Scientific Corporation is a leading biomedical/biotechnology engineering Company involved in the global production of medical devices that are used in interventional medical specialties, such as interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.

Product Portfolio:

The product portfolio of Boston Scientific Corporation for enteral stenting procedures contains AXIOS, Advanix Biliary Stent with NaviFlex RX Delivery System, Epic Biliary Endoscopic Stent, Advanix Pancreatic Stent and NaviFlex RX Pancreatic Delivery System, and NaviFlex Pushers, Ultraflex Esophageal Stent System, WallFlex Biliary RX Fully Covered Stent System, WallFlex Colonic Stents, WallFlex Duodenal Stent, WallFlex Esophageal Stents, Agile Esophageal Fully & Partially Covered Stent System, WallFlex Colonic and Duodenal Soft Stent System with Anchor Lock Delivery System.

The global enteral stenting procedures market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.